U.S. Consumer Services Stock News

NYSE:ALIT
NYSE:ALITProfessional Services

Why Alight (ALIT) Is Down 42.0% After Massive Goodwill Impairment And Dividend Suspension - And What's Next

Alight, Inc. reported fourth-quarter 2025 results showing sales of US$653 million versus US$680 million a year earlier, alongside a goodwill impairment charge of US$803 million that contributed to a full-year net loss of US$3.10 billion. The company is halting its dividend, increasing investment in AI and operational improvements, and has reshaped senior leadership in key Health, Navigation and Leaves solutions while simultaneously completing a sizeable share repurchase program. Next, we...
NYSE:SEM
NYSE:SEMHealthcare

A Look At Select Medical (SEM) Valuation After Recent Share Price Weakness

Select Medical Holdings (SEM) has been drawing attention after recent share moves, with the stock down about 7% over the past week and 13.6% over the past year, despite reports of positive annual revenue and net income growth. See our latest analysis for Select Medical Holdings. The recent 1 day share price return of a 6.65% decline and 7 day share price return of an 8.36% decline suggest momentum has cooled, even though the 90 day share price return of 7.14% and 3 year total shareholder...
NYSE:NNN
NYSE:NNNRetail REITs

NNN REIT (NNN) Valuation Check As New Chair Edward Fritsch Takes Over Governance Duties

NNN REIT (NNN) is back in focus after a boardroom shift, with longtime chair Steven D. Cosler retiring and independent director Edward J. Fritsch stepping in as the new Chair on February 18, 2026. See our latest analysis for NNN REIT. The leadership change comes as NNN REIT’s share price, now at $44.35, has recorded a 4.95% 1 month share price return and 8.57% 3 month share price return, while its 1 year total shareholder return sits at 13.55%. This points to gradually building momentum...
NasdaqGS:NFLX
NasdaqGS:NFLXEntertainment

Is Netflix (NFLX) Pricing Look Reasonable After Recent Share Price Pullback

If you are wondering whether Netflix's current share price reflects its long term potential or is baking in too much optimism, it helps to break the story down into hard numbers and valuation checks. The stock last closed at US$78.67, with returns of 2.3% over 7 days, an 8.7% decline over 30 days, a 13.5% decline year to date, a 21.6% decline over 1 year and gains of 148.1% over 3 years and 46.0% over 5 years. Recent coverage has focused on Netflix's ongoing push in content, international...
NYSE:UNH
NYSE:UNHHealthcare

Is It Time To Reassess UnitedHealth Group (UNH) After A 36% One Year Share Price Fall

If you are wondering whether UnitedHealth Group's current share price reflects its underlying worth, you are not alone. This article is set up to help you unpack that question clearly. The stock last closed at US$290, with returns of a 1.1% decline over 7 days, an 18.6% decline over 30 days, a 13.8% decline year to date and a 36.3% decline over 1 year, adding important context for anyone reassessing risk and potential reward. Recent coverage has focused on UnitedHealth Group's role in the...
NasdaqGS:DBX
NasdaqGS:DBXSoftware

How Investors Are Reacting To Dropbox (DBX) Profit Boost, Big Buybacks, and New AI Push

In February 2026, Dropbox reported fourth-quarter and full-year 2025 results showing slightly lower sales but higher net income and earnings per share, completed share repurchases totaling US$1.46 billion across two authorizations, and filed a US$300.47 million shelf registration for an employee stock offering of 12,150,187 Class A shares. Beyond the headline earnings beat, the combination of over US$1 billion in unlevered free cash flow, significant buybacks, and early adoption of...
NasdaqGS:AMD
NasdaqGS:AMDSemiconductor

Did AMD's (AMD) India Helios AI Data Center Blueprint Just Recast Its Infrastructure Ambitions?

In February 2026, Tata Consultancy Services’ HyperVault subsidiary and AMD expanded their collaboration to co-develop “Helios,” a rack-scale AI infrastructure design for India’s national AI initiatives, built around AMD’s Instinct MI455X GPUs, next-generation EPYC “Venice” CPUs, Pensando Vulcano NICs and ROCm software. This AI-ready data center blueprint, supporting up to 200 MW per site and aimed at sovereign AI factories, deepens AMD’s role in large-scale infrastructure projects and could...
NYSE:ANF
NYSE:ANFSpecialty Retail

Assessing Abercrombie & Fitch (ANF) Valuation After Recent Share Price Momentum And Cash Return Plans

Event context and recent share performance Abercrombie & Fitch (ANF) shares have moved within a mixed return profile, with a small 1 day gain of 0.5% and a modest 0.1% return over the past month, alongside a 47% return over the past 3 months. See our latest analysis for Abercrombie & Fitch. At a share price of US$96.41, Abercrombie & Fitch has paired a strong 46.9% 3 month share price return with a more modest 1 year total shareholder return decline of 3.7%. This suggests recent momentum has...
NYSE:SLB
NYSE:SLBEnergy Services

Do SLB’s New Indonesia and Geothermal Deals Clarify Its Energy-Transition Strategy (SLB)?

In February 2026, Mubadala Energy announced it had awarded SLB multiple integrated offshore drilling services contracts for the Tangkulo deepwater gas development and related wells in Indonesia’s Andaman Sea, while Equinor and Star Energy Geothermal also selected SLB for subsea compression upgrades and geothermal drilling support. Together, these wins underscore how SLB’s integrated drilling, subsea compression and geothermal capabilities are being applied across both conventional gas and...
NYSE:HRB
NYSE:HRBConsumer Services

Did H&R Block's (HRB) New AI-Driven Tax Tools Just Redefine Its Digital Innovation Story?

In early February 2026, H&R Block announced a suite of enhancements to its tax preparation services, including AI Tax Assist for 24/7 client support, advanced AI tools for tax professionals, a Smart Product Selector for DIY tier selection, and upgraded technology to help filers locate forms and optimize deductions. This push to blend AI-powered automation with human expertise could reshape how clients interact with H&R Block’s omnichannel tax offerings during the core filing season. Next,...
NYSE:AWR
NYSE:AWRWater Utilities

A Look At American States Water (AWR) Valuation After Earnings, California Rate Hikes And Dividend Increase

American States Water (AWR) just paired its latest earnings release with an approved dividend increase and new California rate hikes, a mix that puts both its income profile and regulated utility cash flows in focus. See our latest analysis for American States Water. Even with the dividend increase and new California rate hikes, American States Water’s share price performance has been fairly subdued. The 7 day share price return shows a 2.6% decline and the year to date share price return is...
NYSE:BYD
NYSE:BYDHospitality

Do Boyd Gaming's (BYD) Steady Dividend Hikes Reveal a Durable Capital Allocation Advantage?

Boyd Gaming Corporation recently increased its quarterly dividend to US$0.20 per share from US$0.18, payable on April 15, 2026, to shareholders of record on March 16, 2026, reinforcing its pattern of returning cash to investors. This fourth consecutive dividend hike, alongside record earnings, balance sheet strengthening, and ongoing online and property investments, highlights management’s emphasis on combining growth projects with regular cash distributions. We’ll now examine how Boyd...
NYSE:ACVA
NYSE:ACVACommercial Services

ACV Auctions’ Softened Revenue Outlook in Tough Used-Car Market Might Change The Case For Investing In ACV Auctions (ACVA)

Online used car auction platform ACV Auctions recently reported earnings after the bell, following a prior quarter where it met revenue expectations but missed its full-year revenue and EBITDA guidance. This latest update comes as the company heads into a period of slower expected revenue growth and heightened scrutiny of how it manages a tougher used-vehicle market and the fallout from a former customer bankruptcy. Next, we’ll examine how ACV’s adjusted revenue guidance amid a challenging...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

How FDA RMAT Status For Zugo-cel Amid Wider Losses At CRISPR Therapeutics (CRSP) Has Changed Its Investment Story

CRISPR Therapeutics AG reported fourth-quarter 2025 revenue of US$864,000 and a net loss of US$130.61 million, with full-year 2025 revenue of US$3.51 million and a net loss of US$581.6 million. Against these weaker financial results, investor attention has shifted to the advancing gene-editing pipeline, including zugo-cel’s FDA Regenerative Medicine Advanced Therapy designation and growing Casgevy commercialization. We’ll now examine how the FDA’s RMAT designation for zugo-cel shapes CRISPR...
NasdaqGM:CDNA
NasdaqGM:CDNABiotechs

AlloHeme Clinical Validation Could Be A Game Changer For CareDx’s (CDNA) Transplant Platform Expansion

On February 12, 2026, CareDx announced pivotal clinical validation results for AlloHeme, an NGS- and AI-powered blood test that detects emerging relapse in AML and MDS patients after allogeneic transplant significantly earlier than traditional bone marrow or marker-specific methods, based on data from the 198-patient ACROBAT study. The successful validation of AlloHeme marks a key step in extending CareDx’s transplant-focused precision medicine platform into hematology and oncology,...
NYSE:COTY
NYSE:COTYPersonal Products

Does Coty’s Pulled FY26 Guidance Under Interim CEO (COTY) Cloud Or Clarify Its Long-Term Story?

In February 2026, Coty withdrew its fiscal 2026 guidance after fiscal second-quarter results came in below plan under newly appointed interim CEO Markus Strobel. This combination of weaker-than-expected results and reduced visibility under new leadership has prompted analysts to re-evaluate Coty’s longer-term outlook and risk profile. We’ll now explore how the withdrawal of FY26 guidance under interim leadership could influence Coty’s existing investment narrative. Invest in the nuclear...
NYSE:SF
NYSE:SFCapital Markets

A Look At Stifel Financial (SF) Valuation After Recent Share Price Swings

Stifel Financial (SF) is back on investors’ radar after recent share price moves, with the stock showing mixed returns over the past month and past 3 months alongside double digit 1 year and multi year total returns. See our latest analysis for Stifel Financial. With the share price at US$119.91, Stifel Financial’s recent 6.5% decline in the 1 month share price return contrasts with its stronger 1 year and multi year total shareholder returns. This suggests earlier optimism is now being...
NYSE:CRH
NYSE:CRHBasic Materials

Is It Too Late To Consider CRH (NYSE:CRH) After Its Strong Multi‑Year Share Price Run?

If you are wondering whether CRH is still reasonably priced after a strong run, this article walks through what the current share price could imply about its underlying value. The stock trades at US$124.04, with returns of 1.0% over 30 days, a 1.5% decline over 7 days, a 1.9% decline year to date, 25.0% over 1 year, 182.5% over 3 years and 210.7% over 5 years on a trailing basis. Recent headlines around CRH have focused on its position as a major building materials group and ongoing interest...
NYSE:KMT
NYSE:KMTMachinery

How Kennametal’s Aerospace Strength and Insider Moves At Kennametal (KMT) Has Changed Its Investment Story

Kennametal recently reported fiscal Q2 2026 results that exceeded analyst expectations on earnings per share and revenue, driven by strength in its aerospace and defense business while it continues to manage rising tungsten costs. At the same time, insider activity, including stock sales by Vice President John Wayne Witt and option exercises by Board Member William Lambert, adds an extra layer of context for investors assessing management’s confidence and capital allocation...
NYSE:CLX
NYSE:CLXHousehold Products

Clorox Leans Into Wellness With GOJO Deal And Home Care Report

Clorox (NYSE:CLX) has agreed to acquire GOJO Industries, the maker of Purell hand sanitizer, expanding its presence in health and hygiene products. The company has also released its "Home Care Redefined" report, outlining how it is thinking about wellness focused consumer needs in home care. These moves point to a more concentrated push into health, hygiene, and consumer wellness offerings across Clorox's portfolio. Clorox, trading at $123.6, sits at an interesting point for investors...
NasdaqGS:ODFL
NasdaqGS:ODFLTransportation

Will Lower Tariff-Driven Input Costs Change Old Dominion Freight Line's (ODFL) Operating Efficiency Narrative?

The U.S. Supreme Court recently struck down tariffs imposed by the Trump administration, a move expected to lower costs for manufacturers and logistics providers that rely on imported parts, materials, and equipment. For Old Dominion Freight Line, reduced tariff-related input costs could help cushion the impact of softer freight volumes and support its emphasis on service quality and efficiency. We’ll now examine how this tariff ruling, and its potential to lower operating costs, interacts...
NYSE:ARES
NYSE:ARESCapital Markets

Assessing Ares Management (ARES) Valuation After Launch Of Second European Direct Lending CLO

Ares Management (ARES) has priced its second European Direct Lending Collateralized Loan Obligation, Ares European Direct Lending CLO II, at over €300 million, drawing attention to the stock as investors assess what this new vehicle might mean. See our latest analysis for Ares Management. The EDL CLO II launch lands at a time when Ares Management’s 1 day share price return of 5.15% and 30 day share price return of 21% sit against a 1 year total shareholder return decline of 27.3%, even though...
NasdaqGM:FOLD
NasdaqGM:FOLDBiotechs

Amicus Therapeutics Q4 Profit Print Tests Bullish Profitability Narratives

Amicus Therapeutics (FOLD) closed out FY 2025 with Q4 revenue of US$185.2 million and basic EPS of US$0.01, alongside net income excluding extra items of US$1.7 million, giving investors fresh data on how the business is converting its top line into earnings. The company has seen quarterly revenue move from US$149.7 million in Q4 2024 to US$185.2 million in Q4 2025, while basic EPS shifted from US$0.05 to US$0.01 over the same period, creating a mixed picture on profitability trends. With...
NYSE:APH
NYSE:APHElectronic

Is It Too Late To Consider Amphenol (APH) After 125% One Year Share Price Surge?

If you are wondering whether Amphenol's current share price lines up with its underlying worth, this article will walk through the key numbers that matter. The stock last closed at US$151.04, with returns of 2.9% over 7 days, 0.0% over 30 days, 8.1% year to date, 125.2% over 1 year, 305.2% over 3 years and 403.4% over 5 years. This raises fair questions about what is already priced in and how perceptions of risk may have shifted. Recent attention on Amphenol has centered on its role as a...